Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

Quixote1818

(28,955 posts)
Wed Jul 29, 2020, 03:22 PM Jul 2020

Large Brazil Study: Brazil study finds no hydroxychloroquine benefit for COVID-19

July 23, 2020, 6:54 PM
Rio de Janeiro (AFP) - A study published Thursday on the use of hydroxychloroquine in Brazil to treat COVID-19 found the drug ineffective, the latest blow to President Jair Bolsonaro's push for its widespread use.

The clinical trial, conducted at 55 hospitals across Brazil and published in the New England Journal of Medicine, tested whether hydroxychloroquine improved the condition of patients with mild to moderate cases of COVID-19, alone or in combination with the antibiotic azithromycin.

Bolsonaro's government has recommended since May that doctors in Brazil's public health system prescribe hydroxychloroquine or the related anti-malaria drug chloroquine, plus azithromycin, from the onset of symptoms of the new coronavirus.

Like US President Donald Trump, whom he admires, Bolsonaro has touted hydroxychloroquine as a treatment for COVID-19.

The far-right leader is even taking the drug himself, after coming down with the virus earlier this month.

However, a slate of randomized controlled trials (RCTs), considered the gold standard for clinical investigation, have found the drug is ineffective against coronavirus and has potentially damaging side effects.

The Brazilian RCT reached the same conclusion.

Brazil has essentially become the world's biggest testing ground for the drugs because of the Bolsonaro government's policy.

"Among patients hospitalized with mild-to-moderate COVID-19, the use of hydroxychloroquine, alone or with azithromycin, did not improve clinical status at 15 days as compared with standard care," said the study, by doctors and researchers from a group called Coalition COVID-19 Brazil.

The group's members comprise two research institutes and six hospitals, including Albert Einstein Hospital in Sao Paulo, considered one of the best in Latin America.

The study, carried out on 667 patients, also found those on hydroxychloroquine developed clinical markers that increased their risk for heart and liver problems.

More: https://news.yahoo.com/brazil-study-finds-no-hydroxychloroquine-benefit-covid-19-005415925.html

1 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
Large Brazil Study: Brazil study finds no hydroxychloroquine benefit for COVID-19 (Original Post) Quixote1818 Jul 2020 OP
Antibiotics to treat bacteria bluedye33139 Jul 2020 #1

bluedye33139

(1,474 posts)
1. Antibiotics to treat bacteria
Wed Jul 29, 2020, 03:35 PM
Jul 2020

That's the part of this mystical communion ritual that makes no sense to me.

The mystical doctrine also appears to be based on the idea that the hydrochloriquine will stuff zinc into the cells, based on some random findings that quinine derivatives and analogs might increase zinc transport.

Then, based upon the mystical formula, "zinc equals immune function," the tripart magical compound is imagined to block the virus entirely.

Latest Discussions»General Discussion»Large Brazil Study: Brazi...